Ulys as of March 31, 2012
Portfolio Holdings for Ulys
Ulys holds 60 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares MSCI Emerging Markets Co m 4 | 10.5 | $86M | 2.0M | 42.95 | |
| Morgan Stanley Dean | 6.8 | $56M | 2.9M | 19.64 | |
| Auxilium Pharmaceuticals | 6.0 | $49M | 2.6M | 18.57 | |
| MetLife (MET) | 5.5 | $45M | 1.2M | 37.35 | |
| Nektar Therapeutics | 4.7 | $39M | 4.9M | 7.92 | |
| Express Scripts | 4.6 | $38M | 700k | 54.18 | |
| Onyx Pharmaceuticals | 4.4 | $36M | 950k | 37.68 | |
| Acorda Therapeutics | 4.2 | $35M | 1.3M | 26.55 | |
| Goldman Sachs (GS) | 3.0 | $25M | 200k | 124.37 | |
| 2.7 | $22M | 35k | 641.24 | ||
| Capital One Financial (COF) | 2.7 | $22M | 400k | 55.74 | |
| Furiex Pharmaceuticals | 2.0 | $16M | 695k | 23.63 | |
| Schlumberger | 2.0 | $16M | 235k | 69.93 | |
| Eli Lilly & Co. (LLY) | 2.0 | $16M | 400k | 40.26 | |
| Hca Holdings (HCA) | 2.0 | $16M | 650k | 24.74 | |
| D Potash Corp Of Saska Tchewan I Common Stock 7 | 1.9 | $16M | 350k | 45.69 | |
| Credit Suisse Group | 1.9 | $16M | 550k | 28.51 | |
| Meritor | 1.7 | $14M | 1.8M | 8.07 | |
| Affymetrix | 1.6 | $13M | 3.0M | 4.27 | |
| Ford Motor Company (F) | 1.5 | $13M | 1.0M | 12.48 | |
| AVANIR Pharmaceuticals | 1.5 | $13M | 3.7M | 3.42 | |
| Lamar Advertising Company | 1.4 | $11M | 350k | 32.41 | |
| Freeport-McMoRan Copper & Gold (FCX) | 1.4 | $11M | 300k | 38.04 | |
| Ivanhoe Mines | 1.3 | $11M | 695k | 15.74 | |
| Cisco Systems (CSCO) | 1.3 | $11M | 500k | 21.15 | |
| Lexicon Pharmaceuticals | 1.3 | $10M | 5.6M | 1.86 | |
| Amarin Corporation (AMRN) | 1.2 | $9.9M | 875k | 11.32 | |
| Ypf S.a.-sponsored Adr dep receipt equ 9 | 1.2 | $9.9M | 350k | 28.41 | |
| Bank of America Corporation (BAC) | 1.2 | $9.6M | 1.0M | 9.57 | |
| Arcos Dorados Holdings (ARCO) | 1.1 | $9.0M | 500k | 18.09 | |
| ImmunoGen | 1.0 | $7.9M | 550k | 14.39 | |
| BioMarin Pharmaceutical (BMRN) | 1.0 | $7.9M | 230k | 34.25 | |
| Citigroup (C) | 0.9 | $7.3M | 200k | 36.55 | |
| Array BioPharma | 0.8 | $6.8M | 2.0M | 3.40 | |
| Pfizer | 0.8 | $6.8M | 300k | 22.65 | |
| Qualcomm | 0.8 | $6.8M | 100k | 68.06 | |
| Bristol Myers Squibb (BMY) | 0.8 | $6.8M | 200k | 33.75 | |
| Arch Coal | 0.8 | $6.4M | 600k | 10.71 | |
| Range Res Corp | 0.7 | $5.8M | 100k | 58.14 | |
| Banco Itau Holding Financeira (ITUB) | 0.7 | $5.8M | 300k | 19.19 | |
| U S Silica Hldgs | 0.6 | $5.2M | 250k | 20.94 | |
| D Fluidigm Corp Del (LAB) | 0.6 | $4.9M | 313k | 15.73 | |
| Cementos Pacasmayo | 0.6 | $4.9M | 425k | 11.45 | |
| Deckers Outdoor Corporation (DECK) | 0.6 | $4.7M | 75k | 63.05 | |
| Citigroup Inc unit | 0.5 | $4.5M | 43k | 103.53 | |
| BRF Brasil Foods SA (BRFS) | 0.5 | $4.0M | 200k | 20.01 | |
| C&j Energy Services | 0.5 | $4.0M | 225k | 17.79 | |
| Maidenform Brands | 0.4 | $3.4M | 150k | 22.51 | |
| Smart Technologies Inc. 'a' class a 8 | 0.4 | $3.3M | 1.1M | 2.97 | |
| Research In Motion | 0.4 | $2.9M | 200k | 14.70 | |
| Ironwood Pharmaceuticals (IRWD) | 0.3 | $2.9M | 217k | 13.31 | |
| Arris | 0.3 | $2.8M | 250k | 11.30 | |
| Agenus (AGEN) | 0.3 | $2.7M | 410k | 6.60 | |
| Tempur Pedic Intl | 0.2 | $1.7M | 20k | 84.45 | |
| Beazer Homes USA | 0.2 | $1.6M | 500k | 3.25 | |
| Threshold Pharmaceutical | 0.1 | $880k | 100k | 8.80 | |
| Biodel | 0.1 | $686k | 1.2M | 0.59 | |
| Pacific Biosci | 0.1 | $684k | 200k | 3.42 | |
| eHealth (EHTH) | 0.1 | $579k | 36k | 16.32 | |
| Microvision Inc *w Exp 07/23/201 5 | 0.0 | $61k | 361k | 0.17 |
